BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26644206)

  • 1. Effect of gene polymorphims on the warfarin treatment at initial stage.
    Liu J; Jiang HH; Wu DK; Zhou YX; Ye HM; Li X; Luo ZY; Guo Z; Zhang YL; Wang YC; Zhang W; Zhou HH; Wang LS
    Pharmacogenomics J; 2017 Jan; 17(1):47-52. PubMed ID: 26644206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy.
    Ferder NS; Eby CS; Deych E; Harris JK; Ridker PM; Milligan PE; Goldhaber SZ; King CR; Giri T; McLeod HL; Glynn RJ; Gage BF
    J Thromb Haemost; 2010 Jan; 8(1):95-100. PubMed ID: 19874474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between CYP2C9 and VKORC1 genetic polymorphisms and efficacy and safety of warfarin in Chinese patients.
    Zhang S; Zhao M; Zhong S; Niu J; Zhou L; Zhu B; Su H; Cao W; Xing Q; Yan H; Han X; Fu Q; Li Q; Chen L; Yang F; Zhang N; Wu H; He L; Qin S
    Pharmacogenet Genomics; 2024 Jun; 34(4):105-116. PubMed ID: 38470454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case-cohort.
    Camilleri E; Ghobreyal M; Bos MHA; Reitsma PH; Van Der Meer FJM; Swen JJ; Cannegieter SC; van Rein N
    Pharmacotherapy; 2024 Jun; 44(6):416-424. PubMed ID: 38686648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VKORC1 and CYP2C9 polymorphisms related to adverse events in case-control cohort of anticoagulated patients.
    Misasi S; Martini G; Paoletti O; Calza S; Scovoli G; Marengoni A; Testa S; Caimi L; Marchina E
    Medicine (Baltimore); 2016 Dec; 95(52):e5451. PubMed ID: 28033245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics of warfarin in a paediatric population: time in therapeutic range, initial and stable dosing and adverse effects.
    Hawcutt DB; Ghani AA; Sutton L; Jorgensen A; Zhang E; Murray M; Michael H; Peart I; Smyth RL; Pirmohamed M
    Pharmacogenomics J; 2014 Dec; 14(6):542-8. PubMed ID: 25001883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetic guided versus standard warfarin dosing for routine clinical care with its pharmacoeconomic impact: a randomized controlled clinical trial.
    Anand A; Hegde NC; Chhabra P; Purohit J; Kumar R; Gupta A; Lad DP; Mohindra R; Mehrotra S; Vijayvergiya R; Kumar B; Sharma V; Malhotra P; Ahluwalia J; Das R; Patil AN; Shafiq N; Malhotra S
    Ann Hematol; 2024 Jun; 103(6):2133-2144. PubMed ID: 38634917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between gene polymorphisms and initial warfarin therapy in patients after heart valve surgery.
    Liu Z; Luo F; Zhao J; Chen W; Gao W; Zhou Z
    Pharmacol Rep; 2024 Apr; 76(2):390-399. PubMed ID: 38457019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Factors Influencing Warfarin Dose in Black-African Patients: A Systematic Review and Meta-Analysis.
    Asiimwe IG; Zhang EJ; Osanlou R; Krause A; Dillon C; Suarez-Kurtz G; Zhang H; Perini JA; Renta JY; Duconge J; Cavallari LH; Marcatto LR; Beasly MT; Perera MA; Limdi NA; Santos PCJL; Kimmel SE; Lubitz SA; Scott SA; Kawai VK; Jorgensen AL; Pirmohamed M
    Clin Pharmacol Ther; 2020 Jun; 107(6):1420-1433. PubMed ID: 31869433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Factors Influencing Warfarin Dose in Han Chinese Population: A Systematic Review and Meta-Analysis of Cohort Studies.
    Zhao Z; Zhao F; Wang X; Liu D; Liu J; Zhang Y; Hu X; Zhao M; Tian C; Dong S; Jin P
    Clin Pharmacokinet; 2023 Jun; 62(6):819-833. PubMed ID: 37273173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VKORC1 variant genotypes influence warfarin response in patients undergoing total joint arthroplasty: a pilot study.
    González Della Valle A; Khakharia S; Glueck CJ; Taveras N; Wang P; Fontaine RN; Salvati EA
    Clin Orthop Relat Res; 2009 Jul; 467(7):1773-80. PubMed ID: 19034590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the complex relationship between vitamin K, gut microbiota, and warfarin variability in cardiac surgery patients.
    Xue L; Singla RK; Qin Q; Ding Y; Liu L; Ding X; Qu W; Huang C; Shen Z; Shen B; Miao L
    Int J Surg; 2023 Dec; 109(12):3861-3871. PubMed ID: 37598356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons learned from the influence of CYP2C9 genotype on warfarin dosing.
    Tidbury N; Preston J; Lip GYH
    Expert Opin Drug Metab Toxicol; 2023 Apr; 19(4):185-188. PubMed ID: 37254883
    [No Abstract]   [Full Text] [Related]  

  • 14. A systematic analysis and comparison of warfarin initiation strategies.
    French B; Wang L; Gage BF; Horenstein RB; Limdi NA; Kimmel SE
    Pharmacogenet Genomics; 2016 Oct; 26(10):445-52. PubMed ID: 27383664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advances in warfarin's anticoagulation therapy in Chinese population after mechanical valve replacement].
    Jia JH; Chen C; Zhang K; Dong R
    Zhonghua Wai Ke Za Zhi; 2024 May; 62(5):461-466. PubMed ID: 38548617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Being precise with anticoagulation to reduce adverse drug reactions: are we there yet?
    Cross B; Turner RM; Zhang JE; Pirmohamed M
    Pharmacogenomics J; 2024 Mar; 24(2):7. PubMed ID: 38443337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetic association study of warfarin safety endpoints in Puerto Ricans.
    Valentín II; Rivera G; Nieves-Plaza M; Cruz I; Renta JY; Cadilla CL; Feliu JF; Seip RL; Ruaño G; Duconge J
    P R Health Sci J; 2014 Sep; 33(3):97-104. PubMed ID: 25244877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of Anticoagulation Following Acenocoumarin in Stroke Patients: Role of Pharmacogenomics and Acquired Factors.
    Dubey AK; Kalita J; Nizami MF; Kumar S; Misra UK
    Ann Indian Acad Neurol; 2024 May; 27(3):274-281. PubMed ID: 38907686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol misuse, genetics, and major bleeding among warfarin therapy patients in a community setting.
    Roth JA; Bradley K; Thummel KE; Veenstra DL; Boudreau D
    Pharmacoepidemiol Drug Saf; 2015 Jun; 24(6):619-27. PubMed ID: 25858232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 vaccination affects short-term anti-coagulation levels in warfarin treatment.
    Liu LH; Zhou YZ; Li TY; Kuang DB; Liang Q; Chen L; Yang DF; Zhang X; Tan SL
    J Thromb Thrombolysis; 2024 Mar; ():. PubMed ID: 38526751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.